<DOC>
	<DOCNO>NCT01523704</DOCNO>
	<brief_summary>The number patient implantable pulse generator ( IPG ) steadily increase Japan cause increment number office follow-ups great burden many hospital . The purpose multicenter randomize study demonstrate BIOTRONIK Home Monitoring system reduce office follow-up visit without compromise patient safety . Patients randomized HM follow-up ( Group 1 ) HM &amp; in-office follow-up ( Group 2 ) followed-up 27 month .</brief_summary>
	<brief_title>Safety Efficacy Study IPG Patient With Home Monitoring</brief_title>
	<detailed_description />
	<mesh_term>Bradycardia</mesh_term>
	<criteria>Indicated IPG implantation Japanese guideline Implanted within last 45 day consider implant BIOTRONIK IPG Home Monitoring Able utilize HM system throughout study Ability give inform consent Geographically stable able return followup 27 month Over 20 year old Patient able understand follow procedure state protocol Contraindicated IPG Japanese guideline Patients currently include another cardiac clinical study Patients expect life period less two year Patients might undergo heart transplantation next two year .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>